
epocrates
New brand monograph - Casgevy (exagamglogene autotemcel)
February 12, 2024

Casgevy (exagamglogene autotemcel) - indicated for 1) sickle cell disease in adult and pediatric patients 12 years and older; and 2) transfusion-dependent beta-thalassemia in adult and pediatric patients 12 years and older.
TRENDING THIS WEEK